RecruitingNCT03441659

ACL Reconstruction: Clinical Outcome

Anterior Cruciate Ligament Reconstruction: Clinical Outcome at Middle and Long Term Follow-Up


Sponsor

Stefano Zaffagnini

Enrollment

1,000 participants

Start Date

Dec 17, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). The patients will be monitored and evaluated preoperatively and also at 6 months and 1, 2 and 5 years after the intervention through a clinical visit or telephone interview. Such assessments will include the administration of questionnaires to determine the patient's functional symptoms and the objective examination of the knee during a medical examination to quantify its stability.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria3

  • Patients who have provided informed written written consent;
  • Patients aged between 18 and 60;
  • Patients undergoing reconstructive surgical treatment of the anterior cruciate ligament (ACL)

Exclusion Criteria2

  • Patients unable to understand and to want;
  • Patients who have not signed informed consent;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREACL reconstruction

Surgical ACL reconstruction


Locations(1)

Stefano Zaffagnini

Bologna, Italia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03441659


Related Trials